Export Region
Europe & New Markets
Future expansion — EU-GMP pathway development and structured entry into regulated markets.
- In development
- Status
- 2027
- Target entry
- Open
- Partnerships
Our operations in Europe & New Markets
Our next horizon is regulated-market entry. We are developing EU-GMP-approved sourcing partnerships and building the pharmacovigilance and serialization infrastructure that CE-regulated and other stringent markets require. We welcome conversations with EU, UK and Australian partners planning 2027-and-beyond portfolios.
Registration
EU-GMP and TGA-approved site partnerships under development; decentralized-procedure and national-filing strategies scoped with European regulatory counsel.
Products in Demand
Initial focus on high-volume solid orals and selected nutraceutical lines where Indian manufacturing offers durable cost advantage under stringent-authority oversight.
Market Information
Regulated markets demand years of preparation and reward it with stability. We are making that investment now — partners who join the pathway early help shape the portfolio.
Import process
- 1EU-GMP / stringent-authority site qualification
- 2Dossier development to EU-CTD / TGA standards
- 3Batch-release and QP arrangements with EU partners
- 4Serialization (FMD) and pharmacovigilance systems
Countries we serve
Enquire about Europe & New Markets
Tell us your country and products — we'll map the registration and supply route.
Ready to discuss your market?
Send us your product list, tender specification or private-label brief. A senior export manager — not a chatbot — replies within one business day.
Or message our export desk on WhatsApp